Bellicum Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The com…

Biotechnology
US, Houston [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of BLCM's Analysis
CIK: 1358403 CUSIP: 079481404 ISIN: US0794814048 LEI: - UEI: -
Secondary Listings
BLCM has no secondary listings inside our databases.